Oncogene - Table of Contents alert Volume 31 Issue 41

TABLE OF CONTENTS Volume 31, Issue 41 (October 2012) In this issue Original Articles Short Communication Oncogenomics Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement AATF represses p53-driven apoptosis after DNA damage Katja Höpker et al ¦ The EMBO Journal Following genotoxic stress, cells activate a complex signalling network to arrest the cell cycle and initiate DNA repair or apoptosis. The tumour suppressor p53 lies at the heart of this DNA damage response. In this article published in EMBOJ the authors identify the transcriptional regulator apoptosis-antagonizing transcription factor (AATF)/Che-1 as a critical regulator of the cellular outcome of the p53 response.   Original Articles Top MiR-663, a microRNA targeting p21WAF1/CIP1, promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma C Yi, Q Wang, L Wang, Y Huang, L Li, L Liu, X Zhou, G Xie, T Kang, H Wang, M Zeng, J Ma, Y Zeng and J-P Yun Oncogene 2012 31: 4421-4433; advance online publication, January 16, 2012; 10.1038/onc.2011.629 Abstract | Full Text MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition A Astanehe, M R Finkbeiner, M Krzywinski, A Fotovati, J Dhillon, I M Berquin, G B Mills, M A Marra and S E Dunn Oncogene 2012 31: 4434-4446; advance online publication, January 16, 2012; 10.1038/onc.2011.617 Abstract | Full Text p38α limits the contribution of MAP17 to cancer progression in breast tumors M V Guijarro, M Vergel, J J Marin, S Muñoz-Galván, I Ferrer, S Ramon y Cajal, G Roncador, C Blanco-Aparicio and A Carnero Oncogene 2012 31: 4447-4459; advance online publication, January 23, 2012; 10.1038/onc.2011.619 Abstract | Full Text Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer S E Jalava, A Urbanucci, L Latonen, K K Waltering, B Sahu, O A Jänne, J Seppälä, H Lähdesmäki, T L J Tammela and T Visakorpi Oncogene 2012 31: 4460-4471; advance online publication, January 23, 2012; 10.1038/onc.2011.624 Abstract | Full Text DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin A Mitra, M E Menezes, L K Pannell, M S Mulekar, R E Honkanen, L A Shevde and R S Samant Oncogene 2012 31: 4472-4483; advance online publication, January 23, 2012; 10.1038/onc.2011.623 Abstract | Full Text Short Communication Top N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer Y Su, J Li, A K Witkiewicz, D Brennan, T Neill, J Talarico and G L Radice Oncogene 2012 31: 4484-4489; advance online publication, December 12, 2011; 10.1038/onc.2011.574 Abstract | Full Text Oncogenomics Top A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic G Tomás, M Tarabichi, D Gacquer, A Hébrant, G Dom, J E Dumont, X Keutgen, T J Fahey, III, C Maenhaut and V Detours Oncogene 2012 31: 4490-4498; advance online publication, January 23, 2012; 10.1038/onc.2011.626 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.